Clinical trials
Phase 1 Renal Insufficiency, Chronic trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| AstraZeneca | 2 |
| Affymax | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Eli Lilly and Company | 1 |
| Javelin Pharmaceuticals | 1 |
| Medical Research Council | 1 |
| Royal Free Hampstead NHS Trust | 1 |
| Tanabe Pharma Corporation | 1 |
| University of Edinburgh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency, Chronic | 12 |
| Hyperparathyroidism, Secondary | 2 |
| Kidney Diseases | 2 |
| Kidney Failure, Chronic | 2 |
| Proteinuria | 2 |
| Anemia | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Fatty Liver | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.